1 year return (CAGR)
223.81%
Regulus Therapeutics Inc Exchange (NASDAQ, USD)
RGLS
-
+0.02 (+0.25%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
49.81%
5 year return (CAGR)
-1.56%
10 year return (CAGR)
-39.70%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
564.95M
Price/Sales
1870.70
Ent value
545.54M
Price/Book
6.51
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-50.96%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 8.15 |
| Daily high | 8.18 |
| Daily low | 8.07 |
| Daily Volume | 0K |
| 1y analyst estimate | 7.00 |
| Beta | 0.37 |
| EPS (TTM) | -0.64 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| RGLS | S&P500 | |
| Current price drop from All-time high | -99.69% | -1.00% |
| Highest price drop | -99.97% | -56.47% |
| Date of highest drop | 27 Mar 2023 | 9 Mar 2009 |
| Avg drop from high | -80.01% | -10.68% |
| Avg time to new high | 65 days | 12 days |
| Max time to new high | 2671 days | 1805 days |
News
No items found